Bacterial infections – pipeline review, h1 2013 - Reports Corner
Upcoming SlideShare
Loading in...5
×
 

Like this? Share it with your network

Share

Bacterial infections – pipeline review, h1 2013 - Reports Corner

on

  • 404 views

Global Markets Direct's, 'Bacterial Infections - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic ...

Global Markets Direct's, 'Bacterial Infections - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bacterial Infections, complete with latest updates, and special features on late-stage and discontinued projects.


https://www.reportscorner.com/reports/23241/Bacterial-Infections-%E2%80%93-Pipeline-Review,-H1-2013/

Statistics

Views

Total Views
404
Views on SlideShare
404
Embed Views
0

Actions

Likes
0
Downloads
1
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Bacterial infections – pipeline review, h1 2013 - Reports Corner Presentation Transcript

  • 1. RC Reports Corner Bacterial Infections – Pipeline Review, H1 2013
  • 2. DescriptionDescription Reports Cornerwww.reportscorner.com Global Markets Direct's, 'Bacterial Infections - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bacterial Infections, complete with latest updates, and special features on late-stage and discontinued projects.
  • 3. Brief SummaryBrief Summary Reports Cornerwww.reportscorner.com Global Markets Direct's, 'Bacterial Infections - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bacterial Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bacterial Infections. Bacterial Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
  • 4. Brief SummaryBrief Summary Reports Cornerwww.reportscorner.com Scope - A snapshot of the global therapeutic scenario for Bacterial Infections. - A review of the Bacterial Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Bacterial Infections pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products.
  • 5. Brief SummaryBrief Summary Reports Cornerwww.reportscorner.com Reasons to buy - Identify and understand important and diverse types of therapeutics under development for Bacterial Infections. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players of the most promising pipeline. - Devise corrective measures for pipeline projects by understanding Bacterial Infections pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • 6. Brief SummaryBrief Summary Reports Cornerwww.reportscorner.com - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
  • 7. Table of ContentsTable of Contents Reports Cornerwww.reportscorner.com Table of Contents Table of Contents 2 Introduction 12 Bacterial Infections Overview 13 Therapeutics Development 14 Bacterial Infections Therapeutics under Development by Companies 16 Bacterial Infections Therapeutics under Investigation by Universities/Institutes 39 Late Stage Products 46 Mid Clinical Stage Products 47 Early Clinical Stage Products 48 Discovery and Pre-Clinical Stage Products 49 Bacterial Infections Therapeutics – Products under Development by Companies 50 Bacterial Infections Therapeutics – Products under Investigation by Universities/Institutes 93 Companies Involved in Bacterial Infections Therapeutics Development 102 Bacterial Infections – Therapeutics Assessment 344
  • 8. Table of ContentsTable of Contents Reports Cornerwww.reportscorner.com Drug Profiles 350 Bacterial Infections Therapeutics – Drug Profile Updates 415 Bacterial Infections Therapeutics – Discontinued Products 444 Bacterial Infections Therapeutics - Dormant Products 453 Bacterial Infections – Product Development Milestones 481 Appendix 488
  • 9. For more informationFor more information Reports Cornerwww.reportscorner.com For more information please visit our website https://www.reportscorner.com/reports/23241/Bacterial-Infections-%E2%80%93- Pipeline-Review,-H1-2013/
  • 10. Reports Corner Thank YouThank You www.reportscorner.com RC Contact us: contact@reportscorner.com